Black Diamond Therapeutics

(NASDAQ) BDTX

Current Price$2.67

Market Cap$147.23M

Since IPO (2020)-93%

5 Year-90%

1 Year+56%

1 Month+24%

Black Diamond Therapeutics Financials at a Glance

Market Cap

$147.23M

Revenue (TTM)

$70.00M

Net Income (TTM)

$22.37M

EPS (TTM)

$0.38

P/E Ratio

6.76

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Price

$2.67

Volume

569,376.584

Open

$2.60

Price

$2.67

Volume

569,376.584

Open

$2.60

Previous Close

$2.65

Daily Range

$2.55 - $2.67

52-Week Range

$1.46 - $4.94

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Price

$2.67

Volume

569,376.584

Open

$2.60

Previous Close

$2.65

Daily Range

$2.55 - $2.67

52-Week Range

$1.46 - $4.94

BDTX News

Black Diamond (BDTX) Q2 Loss Narrows 47%

Motley Fool Markets TeamAug 7, 2025

using a stethoscope listen to the heartbeat of patient (1)

Why Shares of Black Diamond Therapeutics Skyrocketed This Week

James HalleyJun 29, 2023

How Did Last Week's IPOs Perform?

David HaenFeb 6, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Black Diamond Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Mark A. Velleca, MD, PhD

Website

www.blackdiamondtherapeutics.com

Headquarters

Cambridge, MA 02142, US

BDTX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

28%

Net Income Margin

32%

Return on Equity

23%

Return on Capital

16%

Return on Assets

16%

Earnings Yield

14.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$147.23M

Shares Outstanding

57.29M

Volume

569.38K

Avg. Volume

709.98K

Financials (TTM)

Gross Profit

$69.67M

Operating Income

$19.87M

EBITDA

$20.20M

Operating Cash Flow

$29.61M

Capital Expenditure

$0.00

Free Cash Flow

$29.61M

Cash & ST Invst.

$128.65M

Total Debt

$15.07M

Black Diamond Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$66.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$147.23M

N/A

Market Cap/Employee

$6.13M

N/A

Employees

N/A

Net Income

$15.12M

+5.4%

EBITDA

$10.20M

+43.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$113.58M

+48.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$15.07M

-19.8%

Short Term Debt

$0.00

-100.0%

Return on Assets

15.64%

N/A

Return on Invested Capital

15.61%

N/A

Free Cash Flow

$6.79M

+54.9%

Operating Cash Flow

$6.79M

+54.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVTXAvalo Therapeutics, Inc.

AVTXAvalo Therapeutics, Inc.$13.40+1.52%

AARDAardvark Therapeutics, Inc. Common Stock

AARDAardvark Therapeutics, Inc. Common Stock$5.43+4.22%

TNYATenaya Therapeutics, Inc.

TNYATenaya Therapeutics, Inc.$0.69+4.66%

CRBUCaribou Biosciences, Inc.

CRBUCaribou Biosciences, Inc.$1.88-2.08%

FENCFennec Pharmaceuticals Inc.

FENCFennec Pharmaceuticals Inc.$6.49+3.67%

IMRXImmuneering Corporation

IMRXImmuneering Corporation$5.24-0.19%

IVAInventiva S.A.

IVAInventiva S.A.$5.13+3.85%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.91+0.04%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

Questions About BDTX

What is the current price of Black Diamond Therapeutics?

Black Diamond Therapeutics is trading at $2.65 per share.

What is the 52-week range for Black Diamond Therapeutics?

Over the past 52 weeks, Black Diamond Therapeutics has traded between $1.46 and $4.94.

How much debt does Black Diamond Therapeutics have?

As of the most recent reporting period, Black Diamond Therapeutics reported total debt of $18.78M.

How much cash does Black Diamond Therapeutics have on hand?

Black Diamond Therapeutics reported $20.99M in cash and cash equivalents in its most recent financial results.

What is Black Diamond Therapeutics’s dividend yield?

Black Diamond Therapeutics does not currently have a dividend yield.

Black Diamond Therapeutics

Black Diamond Therapeutics Financials at a Glance

BDTX News

Black Diamond (BDTX) Q2 Loss Narrows 47%

Why Shares of Black Diamond Therapeutics Skyrocketed This Week

How Did Last Week's IPOs Perform?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Black Diamond Therapeutics

BDTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Black Diamond Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BDTX

What is the current price of Black Diamond Therapeutics?

What is the 52-week range for Black Diamond Therapeutics?

How much debt does Black Diamond Therapeutics have?

How much cash does Black Diamond Therapeutics have on hand?

What is Black Diamond Therapeutics’s dividend yield?

Premium Investing Services